Oberweis Asset Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.7M Buy
709,714
+81,600
+13% +$779K 0.14% 145
2026
Q1
$5.73M Buy
628,114
+11,500
+2% +$96.4K 0.17% 142
2025
Q4
$4.59M Buy
616,614
+14,900
+2% +$107K 0.17% 150
2025
Q3
$4.03M Hold
601,714
0.15% 154
2025
Q2
$3.98M Hold
601,714
0.17% 150
2025
Q1
$5.51M Hold
601,714
0.27% 125
2024
Q4
$6.32M Buy
601,714
+90,800
+18% +$1.07M 0.3% 121
2024
Q3
$6.11M Buy
510,914
+130,000
+34% +$1.12M 0.31% 124
2024
Q2
$2.19M Buy
+380,914
New +$2.09M 0.13% 171

Other funds holding BVS

Oberweis Asset Management's BVS Position: Q2 2026 in Review

Oberweis Asset Management increased its Bioventus (BVS) stake by 13% in Q2 2026, buying an estimated $779K and bringing the position to 709,714 shares worth $6.7M. The position accounts for 0.14% of the portfolio, ranked #145.

Oberweis Asset Management first reported a position in BVS in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Oberweis Asset Management held 709,714 shares of Bioventus worth $6.7M as of Q2 2026.
  • Oberweis Asset Management bought 81,600 Bioventus shares in Q2 2026, an estimated $779K.
  • Bioventus made up 0.14% of Oberweis Asset Management's portfolio in Q2 2026, its #145 holding.
  • Oberweis Asset Management first reported a position in Bioventus in Q2 2024 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.